EyePoint (EYPT) Revenue Growth (3y) (2013 - 2026)
EyePoint (EYPT) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 | -55.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.09% |
| Dec 31, 2025 | -61.10% |
| Sep 30, 2025 | -54.13% |
| Jun 30, 2025 | -22.74% |
| Mar 31, 2025 | 38.05% |
| Dec 31, 2024 | 0.13% |
| Sep 30, 2024 | 5.12% |
| Jun 30, 2024 | 1.69% |
| Mar 31, 2024 | 16.85% |
| Dec 31, 2023 | 25.30% |
| Sep 30, 2023 | -1.06% |
| Jun 30, 2023 | 30.23% |
| Mar 31, 2023 | 0.86% |
| Dec 31, 2022 | 6.85% |
| Sep 30, 2022 | 58.61% |
| Jun 30, 2022 | 17.06% |
| Mar 31, 2022 | 66.54% |
| Dec 31, 2021 | 57.98% |
| Sep 30, 2021 | 62.04% |
| Jun 30, 2021 | 76.36% |